Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Rogers Corp. (NY: ROG)
48.47 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Rogers Corp.
 
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Equinix Among Technology's Biggest Movers on November 5, 2012
November 05, 2012
The Nasdaq has climbed 0.1%, the S&P 500 is trading down 0.3% and the Dow has fallen 0.3% after the morning's trading. The technology sector is a category of stocks relating to the research, developme... Read More
from Investopedia Advisor Commentary
Time Warner Cable and Other NYSE Stocks Making Big Moves on November 5, 2012
November 05, 2012
The Nasdaq is up 0.1%, the S&P 500 is down 0.3% and the Dow has declined 0.3% this morning. Also known as the "Big Board", the NYSE relied for many years on floor trading only, using the open outcry s... Read More
from Investopedia Advisor Commentary
Trading Radar for 11/05: Humana (HUM), Tesla Motors (TSLA), Zillow (Z), Express Scripts (ESRX), Time Warner Cable (TWC) Report
November 02, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7839724 for the full story. Read More
from StreetInsider.com News Articles
UK cost agency backs melanoma drugs after price cuts
November 01, 2012
LONDON, Nov 2 (Reuters) - Two new drugs for skin cancer have been recommended for use on Britain's state-run health service after the rival manufacturers - Roche and Bristol-Myers Squibb - agreed to... Read More
category companyNews
from Reuters: Company News
Companies Delay Earnings Reports Due to Hurricane
October 29, 2012
Several companies scheduled to report quarterly earnings results announced they would postpone their release due to the hurricane. Read More
category Investing/Investment Strategy , Investing/Stock Market
from CNBC.com News
Semiconductors Stocks, Including NXP, Making Big Moves on October 19, 2012
October 19, 2012
The Nasdaq has fallen 1.6%, the S&P 500 is down 1% and the Dow has decreased 1.1% on a bad morning for the market. The Semiconductors sector (XLK) is down 1.3%, outperforming the market overall. Curre... Read More
from Investopedia Advisor Commentary
Roche declines comment on Illumina interest
October 16, 2012
ZURICH, Oct 16 (Reuters) - Swiss drugmaker Roche Holding AG d eclined to comment on Tuesday on market talk it m ight reconsider its bid for U.S. gene-sequencing company Illumina. Read More
category companyNews
from Reuters: Company News
Infosys profit to rise 25 pct as global clients look to squeeze costs
October 11, 2012
BANGALORE, Oct 12 (Reuters) - Infosys, India's second-ranked software services provider, is likely to report a 25 percent increase in quarterly profit on Friday, as European firms come under pressure... Read More
category companyNews
from Reuters: Company News
UPDATE 2-Roche, Lilly drugs set for Alzheimer's prevention trial
October 10, 2012
* Focus on patients with gene mutations that put them at risk early Read More
category companyNews
from Reuters: Company News
Broadcom and Other Big Movers In Semiconductors on October 9, 2012
October 09, 2012
The market is currently down, with the Nasdaq slipping 1.7%, the S&P 500 decreasing 0.8% and the Dow down 0.7%. The Semiconductors sector (XLK) is down 1.4%, outperforming the market overall. Currentl... Read More
from Investopedia Advisor Commentary
CORRECTED-Novartis CEO keen to keep dividend, big M&A not likely
October 08, 2012
 Read More
category companyNews
from Reuters: Company News
CORRECTED-Novartis CEO keen to keep dividend, big M&A not likely
October 08, 2012
(In ninth paragraph, corrects CEO reference to currency effects to full year, from third quarter) Read More
category companyNews
from Reuters: Company News
Novartis CEO keen to keep dividend, big M&A not likely-paper
October 07, 2012
* No cost-cutting plan in works following Diovan patent loss Read More
category companyNews
from Reuters: Company News
PRESS DIGEST - Wall Street Journal - Oct 5
October 05, 2012
Oct 5 (Reuters) - The following are the top stories in the Wall Street Journal on Friday. Reuters has not verified these stories and does not vouch for their accuracy. Read More
category companyNews
from Reuters: Company News
UPDATE 2-Cancer trials show 1 year on Roche's Herceptin is best
October 01, 2012
* Experts say key message is one year of Herceptin is best Read More
category companyNews
from Reuters: Company News
Semiconductors Stocks, Including Universal, Making Big Moves on September 18, 2012
September 18, 2012
After the morning's trading, the Nasdaq has risen 0.1%, the S&P 500 has been relatively flat and the Dow is trading up 0.1%. The Semiconductors sector (XLK) is unchanged so far today and here are its... Read More
from Investopedia Advisor Commentary
TEXT-S&P raises Roche Holding to 'AA'
September 17, 2012
Overview -- Switzerland-based pharmaceuticals and diagnostics group Roche Holding AG continues to display strong operating performance. -- We believe the group's financial policy has become more... Read More
category companyNews
from Reuters: Company News
Lilly's Alimta combination cancer therapy fails trial
September 06, 2012
Sept 6 (Reuters) - Eli Lilly and Co said a late-stage trial testing its lung cancer drug Alimta failed to meet the main study goal of improving overall survival of patients. Read More
category companyNews
from Reuters: Company News
Clean Harbors (CLH) Announces Transition of Senior Executives
August 20, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7673882 for the full story. Read More
from StreetInsider.com News Articles
The Week in Review: Tigermed, a Hangzhou CRO, Plans IPO
August 04, 2012
Tigermed Consulting, the clinical-stage CRO headquartered in Hangzhou, will stage an IPO on the ChiNext exchange, with pricing expected August 6; Covidien officially opened its China medical device R&D... Read More
from ChinaBio® Today
UPDATE 4-FDA approves Sanofi/Regeneron colon cancer drug
August 03, 2012
* Prolonged survival, delayed disease progression in trial Read More
category companyNews
from Reuters: Company News
Unusual 11 Mid-Day Movers 08/01: (CDZI) (SIMG) (RFP) Higher; (SREV) (DRIV) (KCG) Lower
August 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7622125 for the full story. Read More
from StreetInsider.com News Articles
Allergan and Other NYSE Stocks Making Big Moves
August 01, 2012
After this morning's trading, the market is looking good. The Nasdaq has increased 0.1%; the S&P 500 is trading up 0.5%; and the Dow has climbed 0.4%. The NYSE is a stock exchange based in New York Ci... Read More
from Investopedia Advisor Commentary
Rogers Corp. (ROG) Tops Q2 EPS by 7c
July 31, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7618839 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-FDA rejects expanded use of Regeneron drug for gout
July 30, 2012
July 30 (Reuters) - Regeneron Pharmaceuticals Inc said U.S. regulators have denied approval for it to expand use of its Arcalyst drug to prevent gout flares, asking that the company provide more... Read More
category companyNews
from Reuters: Company News
Trading Radar for 07/31: US Steel (X), Coach (COH), Electronic Arts (EA), UBS AG (UBS), Goodyear(GT) Report
July 30, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7615236 for the full story. Read More
from StreetInsider.com News Articles
Roche to Hire 1,000 New Employees in China
July 30, 2012
Roche will hire an additional 1,000 people in China over the next year, bringing its China total to more than 6,000, according to Severin Schwan, CEO of the Swiss biopharma. A few years ago, the... Read More
from ChinaBio® Today
UPDATE 2-US advisers back Roche drug for diabetic eye condition
July 26, 2012
WASHINGTON, July 26 (Reuters) - A U.S. Food and Drug Administration advisory panel recommended Roche Holding AG's Lucentis eye drug for treatment of diabetic macular edema, a leading cause of vision... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Regeneron boosts Eylea sales forecast - again
July 25, 2012
July 25 (Reuters) - Regeneron Pharmaceuticals Inc significantly boosted its 2012 sales forecast for its new eye drug Eylea for the third time this year as second-quarter sales of the sight-restoring... Read More
category companyNews
from Reuters: Company News
UPDATE 1-US FDA staff questions dosing of Roche eye drug
July 24, 2012
WASHINGTON, July 24 (Reuters) - U.S. drug reviewers on Tuesday said Roche Holding AG's eye drug Lucentis appeared to help diabetic patients with a vision-robbing eye condition, but questioned whether... Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here